FDA records identify Physio-Control, Inc. as the applicant on premarket approval P160026 and several supplements to it, all classified under product code MKJ, automated external defibrillators (non-wearable), with a cardiovascular advisory committee. The original approval, P160026, covers the LIFEPAK 1000 Defibrillator, LIFEPAK 20 and 20E Defibrillator/Monitors, LIFEPAK 15 Monitor/Defibrillator and associated lithium-ion rechargeable batteries, with a decision date of July 2, 2018. Later supplements in the same file address manufacturing process changes and a component design change rather than new device families. The records describe the applicant and its filed device scope; they do not establish corporate ownership, headquarters or commercial status. [5][1][4]
The P160026 file and its device scope
P160026 was approved on July 2, 2018, naming the LIFEPAK 1000 Defibrillator, LIFEPAK 1000 lithium-ion rechargeable battery, LIFEPAK 20 Defibrillator/Monitor (refurbished), LIFEPAK 20E Defibrillator/Monitor, LIFEPAK 15 Monitor/Defibrillator and the LIFEPAK lithium-ion rechargeable battery for the LIFEPAK 15. The record lists the applicant as Physio-Control, Inc. at an address in Redmond, Washington, and classifies the devices under regulation number 870.5310. FDA establishment registration and device listing records for product code MKJ name the LIFEPAK 1000, 15, 20, 20E and 35 under the same classification. [5][9]
Recent supplements: process and supplier changes
Three 30-Day Notice supplements decided in late 2026 concern manufacturing rather than new indications. S076, received September 29, 2026 and decided October 29, 2026, covers a supplier manufacturing process change associated with the high energy storage capacitor for the LIFEPAK 35 monitor/defibrillator. S074, received September 2, 2026 and decided September 24, 2026, covers implementation of an automated inspection process for the LIFEPAK 1000, 20, 20E and 15 devices. S073, received August 13, 2026 and decided September 10, 2026, covers removal of an incoming inspection process step for the LIFEPAK 15 monitor/defibrillator. All three carry the OK30 decision code. [1][2][3]
A design change to the LIFEPAK 35
Supplement S069, received June 4, 2026 and decided September 2, 2026, was approved as a Real-Time Process supplement for a minor design change to the EtCO2 module of the LIFEPAK 35. Its supplement reason is listed as change design/components/specifications/material. This is the only record in the set describing a component design change rather than a manufacturing process change. [4]
Product descriptions from the manufacturer
Stryker's published LIFEPAK 35 pages describe the device as a monitor/defibrillator for hospital and EMS use, with a touchscreen and clinical decision support tools, and reference an AED algorithm paper by de Graaf and colleagues in Resuscitation (2021). Those descriptions are the manufacturer's own product statements; the FDA records cited here document the applicant and filing scope, not performance claims. Corporate relationships between Physio-Control, Inc. and any brand named on manufacturer pages are not established by these filings. [7][10]





